Novartis ' s New Treatment for Hives Outperforms Xolair in Trials Novartis ' s New Treatment for Hives Outperforms Xolair in Trials

Novartis said on Tuesday it was taking its experimental medicine ligelizumab to late-stage trials after the drug showed signs of outperforming existing product Xolair in treating severe urticaria.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology News Source Type: news